Tuesday, July 1, 2025 7/1/2025

Th17 extracellular trap-mediated antimicrobial host defense in acne vulgaris

Award Number: R01AR081337
ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/06/2022
PERIOD OF PERFORMANCE END DATE: 06/30/2027

Group Awards By:

View Award Description

Th17 extracellular trap-mediated antimicrobial host defense in acne vulgaris - PROJECT SUMMARY Our recent work identifying C. acnes-induced T cell extracellular traps (TETs) employed novel technologies and in-so-doing made several critical observations, that C. acnes phylotypes can drive the differentiation of TH17 cell into either antimicrobial or non-antimicrobial TH17 cells. In turn, antimicrobial TH17 cells release TETs that entangle and kill bacteria. These observations, along with supporting publications, leads directly to this proposal. Importantly, while this proposal has major implications in improving our understanding of T cell-microbe interactions, it is purposefully designed to interrogate the mechanisms by which C. acnes phylotypes activate T cell subsets to release mitochondria-derived extracellular traps (mtETs) both broadly and mechanistically through innovative translational research as a critical next step. To achieve its goals, this grant builds on ample preliminary findings of i) confocal live imaging demonstrating a catapult-like release of mtETs independent of T cell death, and ii) single cell RNA sequencing data (scRNA-seq) showing elevated expression of mitochondrial- associated genes in T cell subsets from acne lesions but not in nonlesional skin. The mechanisms governing the induction, release and the role of mtETs in acne are unknown . Our central hypothesis is that C. acnes-induced T cell extracellular trap formation involves multiple mechanisms that either ameliorate or potentiate the inflammatory response in acne. To test this, we will determine the mechanism by which C. acnes induce mtETs release from T cells (Aim 1), and identify proteins associated with mtETs including their antimicrobial activity against C. acnes (Aim 2). Our strategy will include: classical immunological techniques involving T cell cloning to dissect the immune effector functions that underlie T cell-mediated antimicrobial host defense; confocal live imaging to define mechanisms of mtETs release and mitochondrial dynamics during mtETs formation; Mass spectrometry analysis to determine protein composition of mtETs and state-of-the-art scRNA-seq experiments to compute mitochondrial gene signatures and to define the T cell subsets and immune circuits present in acne lesions. This contribution is critical as, our studies will make significant conceptual advances in understanding how C. acnes phylotypes shape T cell immune responses in acne skin. The identification of inflammatory and/or antimicrobial proteins associated with mtETs can ultimately guide the design of new “druggable” host targets to ameliorate inflammatory acne and other skin diseases caused by dysbiosis.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $539,911 )
2024	2024	UNIVERSITY OF CALIFORNIA, LOS ANGELES	10889 WILSHIRE BLVD STE 700	LOS ANGELES	CA	90024	LOS ANGELES	USA	Arthritis, Musculoskeletal and Skin Diseases Research	001	3	6/21/2024	NON-COMPETING CONTINUATION	$411,954
2024	2024	UNIVERSITY OF CALIFORNIA, LOS ANGELES	10889 WILSHIRE BLVD STE 700	LOS ANGELES	CA	90024	LOS ANGELES	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	2	3/29/2024	SUPPLEMENT FOR EXPANSION	$34,270
2024	2024	UNIVERSITY OF CALIFORNIA, LOS ANGELES	10889 WILSHIRE BLVD STE 700	LOS ANGELES	CA	90024	LOS ANGELES	USA	Arthritis, Musculoskeletal and Skin Diseases Research	002	3	7/9/2024	SUPPLEMENT FOR EXPANSION	$93,687
														Subtotal = $539,911

Issue Date FY: 2023 ( Subtotal = $424,697 )
2023	2023	UNIVERSITY OF CALIFORNIA, LOS ANGELES	10889 WILSHIRE BLVD STE 700	LOS ANGELES	CA	90024	LOS ANGELES	USA	Arthritis, Musculoskeletal and Skin Diseases Research	001	2	7/1/2023	NON-COMPETING CONTINUATION	$424,697
2023	2022	UNIVERSITY OF CALIFORNIA, LOS ANGELES	10889 WILSHIRE BLVD STE 700	LOS ANGELES	CA	90024	LOS ANGELES	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	1	11/29/2022	NEW	$0
														Subtotal = $424,697

Issue Date FY: 2022 ( Subtotal = $437,013 )
2022	2022	UNIVERSITY OF CALIFORNIA, LOS ANGELES	10889 WILSHIRE BLVD STE 700	LOS ANGELES	CA	90024	LOS ANGELES	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	1	9/6/2022	NEW	$437,013
														Subtotal = $437,013

Grand Total All Awards = $1,401,621

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Th17 extracellular trap-mediated antimicrobial host defense in acne vulgaris

Award Number: R01AR081337

ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/06/2022

PERIOD OF PERFORMANCE END DATE: 06/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer